Efficacy and safety of Guipi Decoction combined with conventional Western medicine in the treatment of insomnia with deficiency of heart and spleen: a meta-analysis
Hui-qin Chen, Zhogqing Dou, Sirui Liu, H-L. Dong, Di Zhang, Shenjun Wang
{"title":"Efficacy and safety of Guipi Decoction combined with conventional Western medicine in the treatment of insomnia with deficiency of heart and spleen: a meta-analysis","authors":"Hui-qin Chen, Zhogqing Dou, Sirui Liu, H-L. Dong, Di Zhang, Shenjun Wang","doi":"10.53388/2022020203","DOIUrl":null,"url":null,"abstract":"Objective: To systematically evaluate the efficacy and safety of Guipi Decoction combined with Western medicine in the treatment of insomnia with deficiency of heart and spleen. Methods: English databases (PubMed, Web of Science, The Cochrane Library, EMBASE) and Chinese databases (CNKI, Wanfang database, China Biomedical Literature Service System, VIP database) were searched by computer. Randomized controlled trials of Guipi Decoction on insomnia with deficiency of heart and spleen were searched from the database construction to November 2021.After the first and second authors independently screened the literature, extracted the data and evaluated the risk of bias in the included studies, meta-analysis was performed using RevMan5.3 software. Results: A total of 9 RCTS were included after screening, including 914 patients.Meta-analysis results showed that: Total effective rate [RR=1.22,95%CI (1.16,1.30), P < 0.00001], total PSQI score [MD=-3.05,95%CI (-3.96, -2.14), P =0.008], number of night awakening times [[MD=-1.18, 95%CI(-1.42, -0.94), P < 0.00001], adverse reaction rate [RR=0.32, 95%CI (0.21,0.51), P < 0.00001] were better than the control group, and the differences were statistically significant. Conclusion: The current evidence shows that, compared with pure using conventional western medicine, belongs to the spleen decoction combined western medicine therapy, cases both deficiency type of insomnia in the total effective rate, reducing the total PSQI score (improve sleep quality, sleep efficiency, sleep disorder, daytime function, etc.), reducing frequency of nighttime awakening, security, have more advantages. However, due to the limitation of the quality and quantity of articles included in the study, more randomized, double-blind, large-sample clinical studies are needed to confirm the above conclusions.","PeriodicalId":61578,"journal":{"name":"亚洲毒理学研究","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"亚洲毒理学研究","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.53388/2022020203","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Objective: To systematically evaluate the efficacy and safety of Guipi Decoction combined with Western medicine in the treatment of insomnia with deficiency of heart and spleen. Methods: English databases (PubMed, Web of Science, The Cochrane Library, EMBASE) and Chinese databases (CNKI, Wanfang database, China Biomedical Literature Service System, VIP database) were searched by computer. Randomized controlled trials of Guipi Decoction on insomnia with deficiency of heart and spleen were searched from the database construction to November 2021.After the first and second authors independently screened the literature, extracted the data and evaluated the risk of bias in the included studies, meta-analysis was performed using RevMan5.3 software. Results: A total of 9 RCTS were included after screening, including 914 patients.Meta-analysis results showed that: Total effective rate [RR=1.22,95%CI (1.16,1.30), P < 0.00001], total PSQI score [MD=-3.05,95%CI (-3.96, -2.14), P =0.008], number of night awakening times [[MD=-1.18, 95%CI(-1.42, -0.94), P < 0.00001], adverse reaction rate [RR=0.32, 95%CI (0.21,0.51), P < 0.00001] were better than the control group, and the differences were statistically significant. Conclusion: The current evidence shows that, compared with pure using conventional western medicine, belongs to the spleen decoction combined western medicine therapy, cases both deficiency type of insomnia in the total effective rate, reducing the total PSQI score (improve sleep quality, sleep efficiency, sleep disorder, daytime function, etc.), reducing frequency of nighttime awakening, security, have more advantages. However, due to the limitation of the quality and quantity of articles included in the study, more randomized, double-blind, large-sample clinical studies are needed to confirm the above conclusions.
目的:系统评价桂皮汤联合西药治疗心脾虚型失眠的疗效和安全性。方法:计算机检索英文数据库(PubMed、Web of Science、The Cochrane Library、EMBASE)和中文数据库(CNKI、万方数据库、中国生物医学文献服务系统、VIP数据库)。检索桂皮汤治疗心脾虚型失眠的随机对照试验,检索数据库建设至2021年11月。第一、二作者独立筛选文献、提取资料并评估纳入研究的偏倚风险后,使用RevMan5.3软件进行meta分析。结果:筛选后共纳入9项RCTS,共纳入914例患者。meta分析结果显示:总有效率[RR=1.22,95%CI (1.16,1.30), P < 0.00001]、PSQI总分[MD=-3.05,95%CI (-3.96, -2.14), P =0.008]、夜醒次数[[MD=-1.18, 95%CI(-1.42, -0.94), P < 0.00001]、不良反应率[RR=0.32, 95%CI(0.21,0.51), P < 0.00001]均优于对照组,差异均有统计学意义。结论:目前证据表明,与单纯采用西药常规治疗相比,属脾汤结合西药治疗,对两虚型失眠症在总有效率、降低PSQI总评分(改善睡眠质量、睡眠效率、睡眠障碍、日间功能等)、减少夜间觉醒次数、安全性等方面均有较大优势。然而,由于纳入研究的文章的质量和数量的限制,需要更多的随机、双盲、大样本临床研究来证实上述结论。